AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2004
Feb 3, 2004
34519_dirs_2004-02-03_514edd6d-b219-4a5c-b796-b85e598a1362.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2004-01-30
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-01-30 | Common Stock, par value $0.10 per share | P | 800 | $3.89 | Acquired | 348760 | Direct |
| 2004-02-03 | Common Stock, par value $0.10 per share | P | 400 | $3.91 | Acquired | 349160 | Direct |
| 2004-02-03 | Common Stock, par value $0.10 per share | P | 1000 | $3.91 | Acquired | 350160 | Direct |
| 2004-02-03 | Common Stock, par value $0.10 per share | P | 500 | $3.86 | Acquired | 350660 | Direct |
Footnotes
F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23